Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166151065> ?p ?o ?g. }
- W3166151065 abstract "Abstract Objectives The use of monoclonal antibody for COVID-19 showed conflicting results in prior studies and its efficacy remains unclear. We aimed to comprehensively determine the efficacy and safety profile of monoclonal antibodies in COVID-19 patients. Methods Sixteen RCTs were analyzed using RevMan 5.4 to measure the pooled estimates of risk ratios (RRs) and standardized mean differences (SMDs) with 95% CIs. Results The pooled effect of monoclonal antibodies demonstrated mortality risk reduction (RR=0.89 (95%CI 0.82-0.96), I 2 =13%, fixed-effect). Individually, tocilizumab reduced mortality risk in severe to critical disease (RR=0.90 (95%CI 0.83-0.97), I 2 =12%, fixed-effect)) and lowered mechanical ventilation requirements (RR=0.76 (95%CI 0.62-0.94), I 2 =42%, random-effects). Moreover, it facilitated hospital discharge (RR=1.07 (95%CI 1.00-1.14), I 2 =60%, random-effects). Meanwhile, bamlanivimab-etesevimab and REGN-COV2 decrease viral load ((SMD=-0.33 (95%CI -0.59 to -0.08); (SMD=-3.39 (95%CI -3.82 to -2.97)). Interestingly, monoclonal antibodies did not improve hospital discharge at day 28-30 (RR=1.05 (95%CI 0.99–1.12), I 2 =71%, random-effects) and they displayed similar safety profile with placebo/standard therapy (RR=1.04 (95%CI 0.76-1.43), I 2 =54%, random-effects). Conclusion Tocilizumab improved hospital discharge and reduced mortality as well as the need for mechanical ventilation, while bamlanivimab-etesevimab and REGN-COV2 reduced viral load in mild to moderate outpatients. In general, monoclonal antibodies are safe and should be considered in severe to critical COVID-19 patients. Registration PROSPERO (CRD42021235112)" @default.
- W3166151065 created "2021-06-22" @default.
- W3166151065 creator A5028664131 @default.
- W3166151065 creator A5069738205 @default.
- W3166151065 creator A5071316963 @default.
- W3166151065 creator A5076722458 @default.
- W3166151065 creator A5085135558 @default.
- W3166151065 date "2021-06-07" @default.
- W3166151065 modified "2023-09-27" @default.
- W3166151065 title "The efficacy and safety of monoclonal antibody treatments against COVID-19: A systematic review and meta-analysis of randomized clinical trials" @default.
- W3166151065 cites W1580407891 @default.
- W3166151065 cites W2001927093 @default.
- W3166151065 cites W2155798268 @default.
- W3166151065 cites W2738544995 @default.
- W3166151065 cites W2766211624 @default.
- W3166151065 cites W2970684805 @default.
- W3166151065 cites W3003322996 @default.
- W3166151065 cites W3003668884 @default.
- W3166151065 cites W3004894342 @default.
- W3166151065 cites W3006703916 @default.
- W3166151065 cites W3009335299 @default.
- W3166151065 cites W3009567932 @default.
- W3166151065 cites W3014050022 @default.
- W3166151065 cites W3016585006 @default.
- W3166151065 cites W3018269482 @default.
- W3166151065 cites W3022970339 @default.
- W3166151065 cites W3038241707 @default.
- W3166151065 cites W3043999082 @default.
- W3166151065 cites W3045715678 @default.
- W3166151065 cites W3063924106 @default.
- W3166151065 cites W3081015435 @default.
- W3166151065 cites W3082355253 @default.
- W3166151065 cites W3084906944 @default.
- W3166151065 cites W3088132250 @default.
- W3166151065 cites W3088243710 @default.
- W3166151065 cites W3089478012 @default.
- W3166151065 cites W3092004162 @default.
- W3166151065 cites W3092136311 @default.
- W3166151065 cites W3092623037 @default.
- W3166151065 cites W3093261446 @default.
- W3166151065 cites W3093604087 @default.
- W3166151065 cites W3093837118 @default.
- W3166151065 cites W3094609299 @default.
- W3166151065 cites W3096119943 @default.
- W3166151065 cites W3096658347 @default.
- W3166151065 cites W3110844195 @default.
- W3166151065 cites W3111431752 @default.
- W3166151065 cites W3115009914 @default.
- W3166151065 cites W3121693389 @default.
- W3166151065 cites W3125712166 @default.
- W3166151065 cites W3127082688 @default.
- W3166151065 cites W3129009830 @default.
- W3166151065 cites W3129869280 @default.
- W3166151065 cites W3130126061 @default.
- W3166151065 cites W3134383271 @default.
- W3166151065 cites W3134674969 @default.
- W3166151065 cites W3137909142 @default.
- W3166151065 cites W4213437390 @default.
- W3166151065 cites W4238573474 @default.
- W3166151065 doi "https://doi.org/10.1101/2021.06.04.21258343" @default.
- W3166151065 hasPublicationYear "2021" @default.
- W3166151065 type Work @default.
- W3166151065 sameAs 3166151065 @default.
- W3166151065 citedByCount "0" @default.
- W3166151065 crossrefType "posted-content" @default.
- W3166151065 hasAuthorship W3166151065A5028664131 @default.
- W3166151065 hasAuthorship W3166151065A5069738205 @default.
- W3166151065 hasAuthorship W3166151065A5071316963 @default.
- W3166151065 hasAuthorship W3166151065A5076722458 @default.
- W3166151065 hasAuthorship W3166151065A5085135558 @default.
- W3166151065 hasBestOaLocation W31661510651 @default.
- W3166151065 hasConcept C126322002 @default.
- W3166151065 hasConcept C142462285 @default.
- W3166151065 hasConcept C142724271 @default.
- W3166151065 hasConcept C159654299 @default.
- W3166151065 hasConcept C168563851 @default.
- W3166151065 hasConcept C203014093 @default.
- W3166151065 hasConcept C204787440 @default.
- W3166151065 hasConcept C2522874641 @default.
- W3166151065 hasConcept C27081682 @default.
- W3166151065 hasConcept C2777080012 @default.
- W3166151065 hasConcept C2777178219 @default.
- W3166151065 hasConcept C2779134260 @default.
- W3166151065 hasConcept C3008058167 @default.
- W3166151065 hasConcept C44249647 @default.
- W3166151065 hasConcept C524204448 @default.
- W3166151065 hasConcept C542903549 @default.
- W3166151065 hasConcept C71924100 @default.
- W3166151065 hasConcept C82789193 @default.
- W3166151065 hasConcept C95190672 @default.
- W3166151065 hasConceptScore W3166151065C126322002 @default.
- W3166151065 hasConceptScore W3166151065C142462285 @default.
- W3166151065 hasConceptScore W3166151065C142724271 @default.
- W3166151065 hasConceptScore W3166151065C159654299 @default.
- W3166151065 hasConceptScore W3166151065C168563851 @default.
- W3166151065 hasConceptScore W3166151065C203014093 @default.
- W3166151065 hasConceptScore W3166151065C204787440 @default.
- W3166151065 hasConceptScore W3166151065C2522874641 @default.
- W3166151065 hasConceptScore W3166151065C27081682 @default.
- W3166151065 hasConceptScore W3166151065C2777080012 @default.